Pitavastatin Reduces Inflammation in Atherosclerotic Plaques in Apolipoprotein E-Deficient Mice with Late Stage Renal Disease. - Wikidata - wikimedia - TriplyDB

Pitavastatin Reduces Inflammation in Atherosclerotic Plaques in Apolipoprotein E-Deficient Mice with Late Stage Renal Disease.

Pitavastatin Reduces Inflammation in Atherosclerotic Plaques in Apolipoprotein E-Deficient Mice with Late Stage Renal Disease.

http://www.wikidata.org/entity/Q35773020

about

Clinical benefits of pitavastatin: focus on patients with diabetes or at risk of developing diabetes.The Anti-Inflammatory Effects of Statins on Coronary Artery Disease: An Updated Review of the Literature.Association of plasma osteopontin with diabetic retinopathy in Asians with type 2 diabetes.

P2860

Q38881481-E2F33592-7DC7-4BFD-BE44-479B5368AAFD Q39277616-14EDA2E7-5D13-4173-874B-1C1F030C73A4 Q49788518-74ABB533-56FF-4808-89A9-E7AC1355D3DC

P2860

Pitavastatin Reduces Inflammation in Atherosclerotic Plaques in Apolipoprotein E-Deficient Mice with Late Stage Renal Disease.

http://www.wikidata.org/entity/Q35773020

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Pitavastatin Reduces Inflammat ...... with Late Stage Renal Disease.

@ast

Pitavastatin Reduces Inflammat ...... with Late Stage Renal Disease.

@en

type

label

Pitavastatin Reduces Inflammat ...... with Late Stage Renal Disease.

@ast

Pitavastatin Reduces Inflammat ...... with Late Stage Renal Disease.

@en

prefLabel

Pitavastatin Reduces Inflammat ...... with Late Stage Renal Disease.

@ast

Pitavastatin Reduces Inflammat ...... with Late Stage Renal Disease.

@en

P1433

Q35773020-567FF14D-6B53-4C1A-9E73-37781CC46C94

P1476

Q35773020-8E58491F-9F1D-4262-8F82-F140DDCCF219

P2093

Q35773020-02404195-F3A5-4458-967D-26C9ED48A9C7

Q35773020-09109E5F-7663-4393-B98D-5BA790ECF6A5

Q35773020-514D8AE9-5B76-41C8-8841-93E320C23C54

Q35773020-5C64A21D-E254-4D31-B73A-99AF57199C0A

Q35773020-940E82AA-4FC0-4DD8-8E7F-AE29060E8B41

Q35773020-994290A2-D02E-496E-9896-340D07AA77A5

Q35773020-A5FD9F1E-64F2-4C7F-B6BF-D5896EA4DC72

Q35773020-BB158891-C330-4E16-98A9-9B478DF63CD9

Q35773020-DBAFB607-842B-4A72-A98F-23F9977900D4

P2860

Q35773020-0E2F07E9-B957-4EE0-A168-8EC60F51DFB5

Q35773020-178DC1EF-D7A8-4DCB-9DDD-8496B09771DD

Q35773020-2C5629D5-6FD1-4E07-A58F-7402F1DF645E

Q35773020-2D37B60C-2A72-48BC-BD85-64CDB72E35B3

Q35773020-36629A28-E277-44AC-96B0-8A9C4594C2E2

Q35773020-39BC902E-56C5-4741-A5A5-04A65208F3E2

Q35773020-3B573E08-28B1-4BD5-B13D-1FC4F5F86A49

Q35773020-3BB56ED9-7E70-4C7E-A2D1-010AFF48BECE

Q35773020-48637BD7-AADE-421B-9AFF-D840359450B5

Q35773020-55AFF74E-E800-499A-96A9-DD5A97BBE85C

P304

Q35773020-D64B1A44-B4A5-48FB-919E-DED2BF653215

P31

Q35773020-92B15141-F404-4050-9A2D-2D20D5586C4D

P356

Q35773020-AB38CB07-E680-4279-8603-F286F67E414A

P407

Q35773020-7CBBA1CA-D02B-4017-B445-0E945D004C71

P433

Q35773020-05EED0A5-035D-4662-91D3-15B70DDAA776

P478

Q35773020-1459376C-E065-4D74-8024-271827C6A522

P50

Q35773020-01C7C3BD-CBCE-4634-B64C-A42305E949B7

Q35773020-5F30848E-30B3-463E-911A-1748E8126CEB

P577

Q35773020-4E9BB4F8-2E17-41A6-8D58-930F2182B6A5

P5875

Q35773020-17854F7C-C1C4-47DB-B0A5-FFCA4595AD9D

P698

Q35773020-8A542D0D-B22E-466A-AC27-3FC4A8000696

P921

Q35773020-A5484FBF-6126-4D11-8A1A-E5371C4A03AD

P932

Q35773020-15C0214A-65E3-417B-AF34-AA3410E4866A

P356

JOURNAL.PONE.0138047

P1433

P1476

Pitavastatin Reduces Inflammat ...... with Late Stage Renal Disease

@en

P2093

Elena Aikawa

http://www.w3.org/2001/XMLSchema#string

Hiroyuki Sonoki

http://www.w3.org/2001/XMLSchema#string

Jian-Guo Wang

http://www.w3.org/2001/XMLSchema#string

Jiro Matsumoto

http://www.w3.org/2001/XMLSchema#string

Jose-Luiz Figueiredo

http://www.w3.org/2001/XMLSchema#string

Jun-ichiro Koga

http://www.w3.org/2001/XMLSchema#string

Manabu Shibasaki

http://www.w3.org/2001/XMLSchema#string

Masanori Aikawa

http://www.w3.org/2001/XMLSchema#string

Sophie E P New

http://www.w3.org/2001/XMLSchema#string

P2860

Phosphate regulates osteopontin gene transcription

Vascular calcification: pathobiology of a multifaceted disease

NK-104, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, reduces osteopontin expression by rat aortic smooth muscle cells

Vascular calcification and aortic fibrosis: a bifunctional role for osteopontin in diabetic arteriosclerosis

Statins suppress apolipoprotein CIII-induced vascular endothelial cell activation and monocyte adhesion

Statins alter smooth muscle cell accumulation and collagen content in established atheroma of watanabe heritable hyperlipidemic rabbits.

An HMG-CoA reductase inhibitor, cerivastatin, suppresses growth of macrophages expressing matrix metalloproteinases and tissue factor in vivo and in vitro.

Statins augment collateral growth in response to ischemia but they do not promote cancer and atherosclerosis.

Phosphate feeding induces arterial medial calcification in uremic mice: role of serum phosphorus, fibroblast growth factor-23, and osteopontin.

The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals.

P304

e0138047

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0138047

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

Thibaut Quillard

Claudia Goettsch

P577

2015-09-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

281778954

http://www.w3.org/2001/XMLSchema#string

P698

26367531

http://www.w3.org/2001/XMLSchema#string

P921

atherosclerosis

P932

4569429

http://www.w3.org/2001/XMLSchema#string